Pathogenic germline variants in SMARCA4 and further cancer predisposition genes in early onset ovarian cancer

Herold N, Schmolling J, Ernst C, Ataseven B, Blümcke B, Schömig-Markiefka B, Heikaus S, Göhring U-J, Engel C, Lampe B, Rhiem K, et al. (2023)
Cancer Medicine .

Zeitschriftenaufsatz | E-Veröff. vor dem Druck | Englisch
 
Download
Es wurden keine Dateien hochgeladen. Nur Publikationsnachweis!
Autor*in
Herold, Natalie; Schmolling, Johanna; Ernst, Corinna; Ataseven, BeyhanUniBi; Blümcke, Britta; Schömig-Markiefka, Birgid; Heikaus, Sebastian; Göhring, Uwe-Jochen; Engel, Christoph; Lampe, Bjoern; Rhiem, Kerstin; Harter, Philipp
Alle
Abstract / Bemerkung
To assess the role of germline pathogenic variants (PVs) in SMARCA4 and further established ovarian cancer (OC) predisposition genes in early onset OC, we investigated a clinical cohort of 206 unrelated OC index patients with an age at diagnosis of OC & LE;40 years using an extended panel of 24 (candidate) cancer predisposition genes. PVs in established OC predisposition genes were most frequent in patients with high grade serous OC (21/62, 33.9%), comparatively rare in patients with epithelial OC other than high grade serous (5/74, 6.8%) or borderline ovarian tumours (2/39, 5.1%) and absent in mucinous OC (0/27). We demonstrate that germline PVs in SMARCA4 unlikely predispose for early onset OC other than SCCOHT.
Stichworte
BRCA mutations; cancer risk factors; gynecological oncology; hereditary; cancer; ovarian cancer; SCCOHT; SMARCA4
Erscheinungsjahr
2023
Zeitschriftentitel
Cancer Medicine
eISSN
2045-7634
Page URI
https://pub.uni-bielefeld.de/record/2980959

Zitieren

Herold N, Schmolling J, Ernst C, et al. Pathogenic germline variants in SMARCA4 and further cancer predisposition genes in early onset ovarian cancer. Cancer Medicine . 2023.
Herold, N., Schmolling, J., Ernst, C., Ataseven, B., Blümcke, B., Schömig-Markiefka, B., Heikaus, S., et al. (2023). Pathogenic germline variants in SMARCA4 and further cancer predisposition genes in early onset ovarian cancer. Cancer Medicine . https://doi.org/10.1002/cam4.6214
Herold, Natalie, Schmolling, Johanna, Ernst, Corinna, Ataseven, Beyhan, Blümcke, Britta, Schömig-Markiefka, Birgid, Heikaus, Sebastian, et al. 2023. “Pathogenic germline variants in SMARCA4 and further cancer predisposition genes in early onset ovarian cancer”. Cancer Medicine .
Herold, N., Schmolling, J., Ernst, C., Ataseven, B., Blümcke, B., Schömig-Markiefka, B., Heikaus, S., Göhring, U. - J., Engel, C., Lampe, B., et al. (2023). Pathogenic germline variants in SMARCA4 and further cancer predisposition genes in early onset ovarian cancer. Cancer Medicine .
Herold, N., et al., 2023. Pathogenic germline variants in SMARCA4 and further cancer predisposition genes in early onset ovarian cancer. Cancer Medicine .
N. Herold, et al., “Pathogenic germline variants in SMARCA4 and further cancer predisposition genes in early onset ovarian cancer”, Cancer Medicine , 2023.
Herold, N., Schmolling, J., Ernst, C., Ataseven, B., Blümcke, B., Schömig-Markiefka, B., Heikaus, S., Göhring, U.-J., Engel, C., Lampe, B., Rhiem, K., Harter, P., Hauke, J., Schmutzler, R.K., Hahnen, E.: Pathogenic germline variants in SMARCA4 and further cancer predisposition genes in early onset ovarian cancer. Cancer Medicine . (2023).
Herold, Natalie, Schmolling, Johanna, Ernst, Corinna, Ataseven, Beyhan, Blümcke, Britta, Schömig-Markiefka, Birgid, Heikaus, Sebastian, Göhring, Uwe-Jochen, Engel, Christoph, Lampe, Bjoern, Rhiem, Kerstin, Harter, Philipp, Hauke, Jan, Schmutzler, Rita K., and Hahnen, Eric. “Pathogenic germline variants in SMARCA4 and further cancer predisposition genes in early onset ovarian cancer”. Cancer Medicine (2023).

Zitationen in Europe PMC

Daten bereitgestellt von Europe PubMed Central.

References

Daten bereitgestellt von Europe PubMed Central.

Export

Markieren/ Markierung löschen
Markierte Publikationen

Open Data PUB

Web of Science

Dieser Datensatz im Web of Science®
Quellen

PMID: 37345881
PubMed | Europe PMC

Suchen in

Google Scholar